REMAP-CAP Trial’s latest information
See REMAP-CAP Trial’s latest information and response to the COVID-19 pandemic at: REMAPCAP.org
March 26, 2020
Menu
See REMAP-CAP Trial’s latest information and response to the COVID-19 pandemic at: REMAPCAP.org
@KertViele Introduction We conduct clinical trials to find effective treatments. Much like Thomas Edison and the light bulb, one trial is rarely enough. In difficult
@KertViele Highly powered clinical trials are expensive. The sample sizes involved are a sum of the information you likely need to answer the question, and
Kert Viele (With thanks to Jeff Wetherington, Helen Zhou, Anna McGlothlin, and Liz Krachey) You are starting a development program. While currently unknown to you,
Kert Viele and Christina Saunders @KertViele My colleague Scott Berry recently presented a webinar on historical borrowing. https://ictr.wpengine.com/webinar-5-historical-borrowing-in-clinical-trials/ This blog post doesn’t require you to
Berry Consultants is once again a sponsor for this year’s American Statistical Association’s (ASA) Joint Statistical Meetings (JSM) on July 27 – August 1, 2019
@KertViele Real world evidence is everywhere these days, bolstered primarily by the FDA motivated discussion of including real world evidence as a supplement or complete
Berry Consultants has recently released several short videos and webinars undertaken in our role as the Innovative Clinical Trials Resource (ICTR) for the National Institute
On October 29, 2018, Berry Consultants proudly released the first in a series of short videos undertaken in our role as the Innovative Clinical Trials
In our first public National Heart, Lung, and Blood Institute (NHLBI) Innovative Clinical Trials Resource (ICTR) webinar, Berry Consultants' Kert Viele will review the value
© 2012-2025 All rights reserved - Berry Consultants